OncoNano Medicine
Dr. Paul A. Bunn, Jr. is Distinguished Professor and the James Dudley Chair in Cancer Research in the Division of Medical Oncology at the University of Colorado Cancer Center of the Univ. of Colorado School of Medicine, where he has practiced and taught since 1984. Dr. Bunn, who is a founding director of the University of Colorado Cancer Center, is a past president of the International Association for the Study of Lung Cancer (IASLC) and the American Society of Clinical Oncology (ASCO). He also served as chairman of the FDA Oncology Drug Advisory Committee.
This person is not in the org chart
This person is not in any offices
OncoNano Medicine
OncoNano Medicine is developing a new class of pH-activated compounds that digitalize and exploit the variability of pH in disease. pH variability is a proven, simple, and effective identifier of diseased tissue providing a foundation for the development of a broad range of highly targeted therapeutics and imaging agents.